LEADER 03866nam  2201285z- 450 
001 9910566482503321
005 20231214133414.0
035   $a(CKB)5680000000037555
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/81038
035   $a(EXLCZ)995680000000037555
100   $a20202205d2022      |y             0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aThe Role of PPARs in Disease
210   $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022
215   $a1 electronic resource (274 p.)
311   $a3-0365-3992-1 
311   $a3-0365-3991-3 
330   $aThis reprint combines recent original manuscripts and reviews covering the multiple functions of peroxisome proliferator-activated receptors in physiology and pathophysiology. Potential applications and limitations of PPAR agonists and antagonists are discussed. All original contributions were published in Cells.
606   $aMedicine$2bicssc
606   $aPhysiology$2bicssc
610   $aperoxisome-proliferator activated receptors
610   $atumor angiogenesis
610   $atumor progression
610   $ametastasis formation
610   $aendothelial cells
610   $aRNA sequencing
610   $aPPARs
610   $atoxicology
610   $apharmacology
610   $aligand
610   $avascular
610   $acoronary artery
610   $alipidomics
610   $aeicosanoids
610   $ainflammation
610   $aCYP450
610   $aperoxisome proliferator-activated receptor
610   $aangiogenesis
610   $aproliferation
610   $ametastasis
610   $aimmortality
610   $aresistance to cell death
610   $agrowth suppressors
610   $aimmune system
610   $acellular metabolism
610   $aPPAR
610   $anuclear receptors
610   $aaddiction
610   $aalcohol
610   $anicotine
610   $aopioids
610   $apsychostimulants
610   $aanimal models
610   $ahuman studies
610   $aAlzheimer?s
610   $arisk factors
610   $aPPAR?
610   $alipids
610   $afatty acids
610   $amodulators
610   $acognition
610   $asex
610   $atherapy
610   $ahypertrophic adipocytes
610   $aPPARG isoforms
610   $aPPARG splicing
610   $adominant-negative isoform
610   $ain vitro adipocytes
610   $aadipogenesis
610   $ahypertrophic obesity
610   $ainsulin-resistance
610   $aperoxisome proliferator-activated receptors (PPARs)
610   $asynthetic agonists
610   $anon-alcoholic fatty liver disease (NAFLD)
610   $anon-alcoholic steatohepatitis (NASH)
610   $afibrosis
610   $aSirtuin1
610   $aperoxisome proliferator-activated receptor-? coactivator-1?
610   $aperoxisome proliferator activated receptors
610   $aobesity
610   $ametabolic syndrome
610   $avitamin B12
610   $afolate
610   $afetal programming
610   $ainherited metabolic disorders
610   $aPGC-1?, disease
610   $akidney
610   $acancer
610   $aAKI
610   $aCKD
610   $anephron
610   $aPKD
610   $acilia
610   $acystogenesis
610   $aligands
610   $aAlzheimer?s disease (AD)
615  7$aMedicine
615  7$aPhysiology
700   $aWagner$b Nicole$4edt$01303406
702   $aWagner$b Kay-Dietrich$4edt
702   $aWagner$b Nicole$4oth
702   $aWagner$b Kay-Dietrich$4oth
906   $aBOOK
912   $a9910566482503321
996   $aThe Role of PPARs in Disease$93027006
997   $aUNINA